Quantcast
Last updated on April 20, 2014 at 8:28 EDT

Latest Abraham L. Pomerantz Stories

2013-12-31 12:22:17

NEW YORK, Dec. 31, 2013 /PRNewswire/ -- Pomerantz Grossman Hufford Dahlstrom & Gross LLP is investigating claims on behalf of investors of Patient Safety Technologies ("Patient Safety" or the "Company") (OTCBB: PSTX) (ISIN: US70322H1068) (CUSIP: 70322H1068) concerning the proposed acquisition of Patient Safety by Stryker Corporation in a transaction valued at approximately $120 million including estimated fees and expenses. The investigation concerns whether the Patient Safety...

2013-12-16 16:23:51

NEW YORK, Dec. 16, 2013 /PRNewswire/ -- Pomerantz Grossman Hufford Dahlstrom & Gross LLP is investigating claims on behalf of investors of Solta Medical, Inc. ("Solta" or the "Company") (NYSE: SLTM) (ISIN: US83438K1034) (CUSIP: 83438K103) concerning the proposed acquisition of Solta by Valeant Pharmaceuticals International, Inc. The investigation concerns whether the Solta directors are breaching their fiduciary duties by failing to adequately shop the Company and maximize...

2013-12-09 20:23:32

NEW YORK, Dec. 9, 2013 /PRNewswire/ -- Pomerantz Grossman Hufford Dahlstrom & Gross LLP is investigating claims on behalf of investors of OSI Systems, Inc. ("OSI Systems" or the "Company")(NASDAQ: OSIS). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 237. The investigation concerns whether OSI Systems and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of...

2013-11-22 16:27:34

NEW YORK, Nov. 22, 2013 /PRNewswire/ -- Pomerantz Grossman Hufford Dahlstrom & Gross LLP is investigating claims on behalf of investors of Violin Memory, Inc, ("Violin Memory" or the "Company")(NYSE: VMEM). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll free, x237. The investigation concerns whether Violin Memory and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of...

2013-11-13 16:26:29

NEW YORK, Nov. 13, 2013 /PRNewswire/ -- Pomerantz Grossman Hufford Dahlstrom & Gross LLP is investigating claims on behalf of investors of ViroPharma, Inc. ("ViroPharma" or the "Company") (NASDAQ: VPHM) (ISIN: US9282411084) (CUSIP: 928241108) concerning the proposed acquisition of ViroPharma by Shire Plc. The investigation concerns whether the ViroPharma directors are breaching their fiduciary duties by failing to adequately shop the Company and maximize shareholder value. Under...

2013-10-24 12:27:05

NEW YORK, Oct. 24, 2013 /PRNewswire/ -- Pomerantz Grossman Hufford Dahlstrom & Gross LLP is investigating claims on behalf of investors of Repros Therapeutics, Inc. ("Repros" or the "Company")(NASDAQ: RPRX). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 237. The investigation concerns whether Repros and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of...

2013-10-09 16:21:17

NEW YORK, Oct. 9, 2013 /PRNewswire/ -- Pomerantz Grossman Hufford Dahlstrom & Gross LLP is investigating claims on behalf of investors of Acorn Energy, Inc. ("Acorn" or the "Company") (NASDAQ: ACFN). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 237. The investigation concerns whether Acorn and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. On...

2013-10-03 12:20:51

NEW YORK, Oct. 3, 2013 /PRNewswire/ -- Pomerantz Grossman Hufford Dahlstrom & Gross LLP is investigating claims on behalf of investors of Tesla Motors, Inc. ("Tesla") (NASDAQ: TSLA). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 237. The investigation concerns whether Tesla and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. In an August 19, 2013...

2013-08-15 20:21:28

NEW YORK, Aug. 15, 2013 /PRNewswire/ -- Pomerantz Grossman Hufford Dahlstrom & Gross LLP is investigating claims on behalf of investors of Volterra Semiconductor, Inc. ("Volterra" or the "Company") (NASDAQ: VLTR) (ISIN: US9287081064) (CUSIP: 928708106) concerning the proposed acquisition of Volterra by Maxim Integrated Products, Inc. in a transaction valued at approximately $605 million equity value or $450 million net of Volterra's cash position of approximately $155 million....

2013-07-31 16:27:27

NEW YORK, July 31, 2013 /PRNewswire/ -- Pomerantz Grossman Hufford Dahlstrom & Gross LLP is investigating claims on behalf of investors of Trius Therapeutics, Inc. ("Trius" or the "Company") (NASDAQ: TSRX) (ISIN: US89685K1007) (CUSIP: 89685K100) concerning the proposed acquisition of Trius by Cubist Pharmaceuticals, Inc. in a transaction valued at $818 million. The investigation concerns whether the Trius directors are breaching their fiduciary duties by failing to adequately...